1. Home
  2. IDN vs BHST Comparison

IDN vs BHST Comparison

Compare IDN & BHST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Intellicheck Inc.

IDN

Intellicheck Inc.

HOLD

Current Price

$7.90

Market Cap

103.0M

Sector

Technology

ML Signal

HOLD

Logo BioHarvest Sciences Inc.

BHST

BioHarvest Sciences Inc.

HOLD

Current Price

$4.36

Market Cap

97.7M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
IDN
BHST
Founded
1994
2007
Country
United States
Canada
Employees
N/A
87
Industry
Computer Software: Prepackaged Software
Sector
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
103.0M
97.7M
IPO Year
2014
N/A

Fundamental Metrics

Financial Performance
Metric
IDN
BHST
Price
$7.90
$4.36
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
2
Target Price
$7.33
$12.00
AVG Volume (30 Days)
512.7K
23.2K
Earning Date
05-12-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
220.00
N/A
EPS
0.06
N/A
Revenue
$4,433,454.00
N/A
Revenue This Year
$11.32
$146.27
Revenue Next Year
N/A
N/A
P/E Ratio
$132.83
N/A
Revenue Growth
23.21
N/A
52 Week Low
$2.30
$4.10
52 Week High
$8.34
$12.80

Technical Indicators

Market Signals
Indicator
IDN
BHST
Relative Strength Index (RSI) 78.32 46.64
Support Level $4.75 $4.27
Resistance Level N/A $5.02
Average True Range (ATR) 0.63 0.14
MACD 0.28 0.02
Stochastic Oscillator 84.76 20.00

Price Performance

Historical Comparison
IDN
BHST

About IDN Intellicheck Inc.

Intellicheck Inc is a trusted industry leader in technology solutions that stop identity theft and fraud with real-time identification authentication and age verification. The group delivers on-demand digital and physical identity verification solutions for KYC, AML, fraud prevention, and age verification needs. The products of the company include solutions for preventing identity fraud across any industry delivered via smartphone, tablet, POS integration or other electronic devices.

About BHST BioHarvest Sciences Inc.

BioHarvest Sciences Inc is the developer and owner of the patented bio-cell growth platform farming technology. This company is the industrial large-scale plant cell growth technology capable of directly and constantly producing active plant ingredients without the necessity to grow the plant itself. The company is focused on leveraging its botanical synthesis technology to develop the next generation of science-based and clinical therapeutic solutions, within two business verticals - nutraceutical health and wellness products such as dietary supplements, and the development of plant cell-based Active Pharmaceutical Ingredients (APIs) that focus on specific medical indications.

Share on Social Networks: